Insmed To Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results From Phase 3B ENCORE Study, At The American Thoracic Society International Conference 2026. -New Data ...
Two major research initiatives are spotlighting emerging priorities in infectious disease science: the role of immunothrombosis in tropical illnesses and the diverse health effects of the gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results